相关实验视频
Updated: Jul 13, 2026

13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.8K
导航病毒性肝炎药物景观:新的发现和持久的挑战. 一个叙事审查
He-Ming Sun1,2,3, Xing-Yu Wang1,2,3, Hong-Qin Xu1,2,3
1Department of Hepatology, Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Jilin University, Changchun, 130021, Jilin, China.
Infectious diseases and therapy
|March 12, 2026
概括
病毒性肝炎是一个全球性的健康挑战,治疗方法因类型而异. 虽然C型肝炎很容易治愈,但B型肝炎,D型肝炎,A型肝炎和E型肝炎需要进一步研究才能找到有效的治疗方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 公共卫生 公共卫生
背景情况:
- 病毒性肝炎是全球肝病的主要原因之一.
- 肝炎A,B,C,D和E是主要的致病因子.
- 世卫组织的目标是到2030年消除病毒性肝炎.
研究的目的:
- 审查病毒性肝炎治疗的近期药理学进展.
- 为了总结当前的治疗策略.
- 为未来的研究方向提供前景.
主要方法:
- 最近科学出版物的文献综述.
- 对当前治疗指南和药物开发管道的分析.
- 综合有关药理干预的信息.
主要成果:
- 型肝炎具有高度有效的治愈疗法 (>95%的治愈率).
- 治疗乙型肝炎和乙型肝炎的治疗方法仍然具有挑战性.
- 对A型和E型肝炎仍然需要有效的治疗方法.
结论:
- 持续的研究对于开发所有肝炎病毒的新疗法至关重要.
- 了解病变发生的进步推动了新药的开发.
- 改善患者的治疗结果和减少全球肝病负担是关键目标.
相关概念视频
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatic Drug Clearance: Role of Transporters
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

